High-Throughput Screening Market Trends

  • Report ID: 3521
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

High-Throughput Screening Market Trends

Growth Drivers

  • Growing Demand for Drugs– On account of the increasing prevalence of chronic disorders across the globe has increased the demand for medicines for treatment. Further, the growing use of HTS for the drug development process is estimated to drive market growth. The number of drug users worldwide is expected to increase by over 10% by 2030.

  • Rising Geriatric Population – Owing to a weak immune system elderly population is more prone to various diseases such as dementia, high blood pressure, and diabetes, which is estimated to drive market growth. As of 2021, the elderly population in India is predicted to increase by over 9%.

  • Increasing Health Spending – Increased government programs and investments in medication research, are anticipated to drive the market growth According to the most recent expenditure data, in 2020, health spending in the US rose by over 9%.

  • Growing Pharmaceutical and Biotechnology Sectors – It is expected that the growing launch of new and advanced drugs, and strong investment in the biotech and pharmaceutical industries, are anticipated to drive market growth. According to estimates, the biotechnology sector in India has grown to a value of over USD 80 billion in 2022.

Challenges

  • Difficulties in Assay Development – To create secondary assays, HTS goes through several difficult stages. It is more costly since the complexity of the assay affects both the time and cost, as a result, it is less adopted by some academic research laboratories.
  • Exorbitant Cost of HTS Instruments– High maintenance costs, and other indirect expenses, increase the total cost of HTS instruments, which is one of the major factors predicted to slow down the market growth.
  • Need for a Large Capital Investment
  • Lack of Skilled Professionals

High-Throughput Screening (HTS) Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

10.7%

Base Year Market Size (2024)

USD 23.33 billion

Forecast Year Market Size (2037)

USD 88.41 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3521
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of high-throughput screening is evaluated at USD 25.35 billion.

The high-throughput screening market size was over USD 23.33 billion in 2024 and is likely to exceed USD 88.41 billion by the end of 2037, growing at over 10.7% CAGR during the forecast period i.e., between 2025-2037. Growing demand for drugs, and the rising geriatric population will boost the market growth.

North America is anticipated to dominate majority industry share by 2037, attributed to growing pharmaceutical industry propelled by rise in chronic illnesses in the region.

The major players in the market include Carna Biosciences, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample